GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EP300 | hg19_v2_chr22_+_41487711_41487798 | -0.38 | 9.1e-09 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_6308881 Show fit | 18.70 |
ENST00000382518.1
ENST00000536586.1 |
CD9 molecule |
|
chrX_-_140271249 Show fit | 17.14 |
ENST00000370526.2
|
leucine zipper, down-regulated in cancer 1 |
|
chr8_+_30300119 Show fit | 17.03 |
ENST00000520191.1
|
RNA binding protein with multiple splicing |
|
chr14_-_69445968 Show fit | 16.35 |
ENST00000438964.2
|
actinin, alpha 1 |
|
chr1_+_10003486 Show fit | 16.21 |
ENST00000403197.1
ENST00000377205.1 |
nicotinamide nucleotide adenylyltransferase 1 |
|
chr2_-_110371720 Show fit | 15.11 |
ENST00000356688.4
|
septin 10 |
|
chr12_+_6309517 Show fit | 14.77 |
ENST00000382519.4
ENST00000009180.4 |
CD9 molecule |
|
chr14_-_69445793 Show fit | 14.56 |
ENST00000538545.2
ENST00000394419.4 |
actinin, alpha 1 |
|
chr14_-_69446034 Show fit | 14.48 |
ENST00000193403.6
|
actinin, alpha 1 |
|
chr11_-_46722117 Show fit | 13.37 |
ENST00000311956.4
|
Rho GTPase activating protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 45.4 | GO:0051639 | actin filament network formation(GO:0051639) |
3.0 | 33.5 | GO:0009414 | response to water deprivation(GO:0009414) |
4.7 | 28.3 | GO:0030421 | defecation(GO:0030421) |
4.9 | 19.6 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.6 | 19.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
3.7 | 18.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.1 | 18.6 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
2.1 | 17.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
1.3 | 17.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.5 | 16.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 45.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 35.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
1.1 | 33.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.6 | 25.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 20.5 | GO:0031012 | extracellular matrix(GO:0031012) |
2.2 | 19.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.5 | 17.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 16.7 | GO:0005856 | cytoskeleton(GO:0005856) |
0.1 | 14.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 14.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 45.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 37.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 33.6 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 28.9 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 26.7 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 23.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.9 | 19.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
4.8 | 19.2 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
2.3 | 18.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 18.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 73.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 42.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 25.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 23.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 20.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 18.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 13.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.4 | 13.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 11.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 10.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 56.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 29.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 29.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.1 | 19.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 17.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 15.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 15.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.9 | 15.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 14.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 10.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |